BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12695169)

  • 21. Comment on: Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register.
    Coates LC; Helliwell PS
    Rheumatology (Oxford); 2010 Sep; 49(9):1793-4; author reply 1794. PubMed ID: 20457729
    [No Abstract]   [Full Text] [Related]  

  • 22. Optic neuritis in a psoriatic arthritis patient treated by infliximab.
    Minami-Hori M; Tsuji H; Takahashi H; Hanada K; Iizuka H
    J Dermatol; 2013 Apr; 40(4):298-9. PubMed ID: 23289758
    [No Abstract]   [Full Text] [Related]  

  • 23. Psoriatic arthritis - treatment update.
    Mease PJ
    Bull NYU Hosp Jt Dis; 2011; 69(3):243-9. PubMed ID: 22035437
    [No Abstract]   [Full Text] [Related]  

  • 24. Acquired hemophilia A and fulminant diabetes mellitus possibly caused by adalimumab in a patient with psoriatic arthritis.
    Yamaguchi T; Itoh M; Umezawa Y; Asahina A; Hanabusa H; Nakagawa H
    J Dermatol; 2017 Mar; 44(3):e3-e4. PubMed ID: 27206322
    [No Abstract]   [Full Text] [Related]  

  • 25. How effective is ustekinumab in controlling psoriatic arthritis?
    Bonifati C; Graceffa D
    Dermatol Ther; 2016 May; 29(3):155-9. PubMed ID: 26626908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporin A in treatment of refractory adult polymyositis/dermatomyositis.
    Wenzel J; Bieber T
    J Rheumatol; 2001 Sep; 28(9):2139. PubMed ID: 11550990
    [No Abstract]   [Full Text] [Related]  

  • 27. Methotrexate: new indication. Psoriatic arthritis: approved at last.
    Prescrire Int; 2007 Oct; 16(91):182. PubMed ID: 17926820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress fracture in long term methotrexate treatment for psoriatic arthritis.
    Wijnands M; Burgers A
    Ann Rheum Dis; 2001 Aug; 60(8):736-9. PubMed ID: 11454635
    [No Abstract]   [Full Text] [Related]  

  • 29. Pyogenic Baker cyst in a patient with psoriatic arthritis during etanercept therapy.
    Wu KY; Yang DH; Chen CW
    Ann Saudi Med; 2015; 35(3):260-2. PubMed ID: 26409803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracapillary glomerulonephritis during etanercept treatment for juvenile psoriatic arthritis.
    Menè P; Franeta AJ; Conti G; Stoppacciaro A; Chimenz R; Fede A; Gallizzi R; Fede C
    Clin Exp Rheumatol; 2010; 28(1):91-3. PubMed ID: 20346246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple pulmonary nodules in a male with psoriatic arthritis.
    Manuel A; Jones Q; Wiggins J
    Eur Respir Rev; 2010 Jun; 19(116):164-5. PubMed ID: 20956187
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pneumonitis caused by gold salts in psoriatic arthritis: report of 2 cases].
    Manero Ruiz FJ; Larraga Palacio R; Herrero Labarga I; Ferrer Peralta M
    An Med Interna; 2002 May; 19(5):237-40. PubMed ID: 12107998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 34. Injection site reactions of adalimumab spreading on the trunk in a psoriatic arthritis patient.
    Kato Y; Kawakami Y; Yamamoto T
    J Dermatol; 2013 Nov; 40(11):931-2. PubMed ID: 24112030
    [No Abstract]   [Full Text] [Related]  

  • 35. Aortitis in a patient with psoriatic arthritis.
    Tufan A; Engin Tezcan M; Kaya A; Mercan R; Oner Y; Ozturk MA
    Mod Rheumatol; 2012 Sep; 22(5):774-7. PubMed ID: 22143340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guideline for anti-TNF-alpha therapy in psoriatic arthritis.
    Kyle S; Chandler D; Griffiths CE; Helliwell P; Lewis J; McInnes I; Oliver S; Symmons D; McHugh N;
    Rheumatology (Oxford); 2005 Mar; 44(3):390-7. PubMed ID: 15695305
    [No Abstract]   [Full Text] [Related]  

  • 37. [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA; Badokin VV
    Ter Arkh; 2003; 75(5):88-90. PubMed ID: 12847908
    [No Abstract]   [Full Text] [Related]  

  • 38. Sulfasalazine-induced extrinsic allergic alveolitis in a patient with psoriatic arthritis.
    Woltsche M; Woltsche-Kahr I; Roeger GM; Aberer W; Popper H
    Eur J Med Res; 2001 Nov; 6(11):495-7. PubMed ID: 11726310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe subcutaneous hematoma in a patient with psoriatic arthritis: Changes of platelet count in psoriatic patients with biologic agents.
    Maya Y; Fujita Y; Nakayama C; Kitamura S; Hata H; Arita K; Shimizu H
    J Dermatol; 2017 Dec; 44(12):1385-1388. PubMed ID: 28733978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis.
    Guidelli GM; Tenti S; Fioravanti A
    Indian J Dermatol Venereol Leprol; 2014; 80(2):187-9. PubMed ID: 24685874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.